E1 ReplicatedModerate confidencePEM not requiredRCTPeer-reviewedMachine draft
Standard · 3 min
Cost-effectiveness of supported self-management for CFS/ME patients in primary care.
Richardson, Gerry, Epstein, David, Chew-Graham, Carolyn et al. · BMC family practice · 2013 · DOI
Quick Summary
This study tested whether two nurse-led treatments for ME/CFS—pragmatic rehabilitation (exercise-based) and supportive listening (counseling-based)—were worth the cost compared to standard care from a GP. Both nurse-led treatments were more expensive than usual care and did not provide enough additional benefit to justify their cost, though some patients saw short-term fatigue improvements with rehabilitation.
Why It Matters
This study addresses a critical gap in ME/CFS management by examining not just clinical effectiveness but cost-effectiveness of commonly proposed treatments. The finding that standard care outperforms expensive nurse-led interventions challenges prevailing treatment recommendations and informs healthcare resource allocation for this often-neglected disease.
Observed Findings
Pragmatic rehabilitation was effective at reducing fatigue in the short term
Treatment as usual (standard GP care) was less expensive than both nurse-led interventions
Treatment as usual produced equivalent or better patient outcomes than supportive listening
The impact of pragmatic rehabilitation on QALYs (quality-adjusted life years) was uncertain
296 ME/CFS patients (diagnosed using Oxford criteria) were included in the cost-effectiveness analysis
Inferred Conclusions
Pragmatic rehabilitation is unlikely to be cost-effective for ME/CFS patients based on this trial's results
Supportive listening should not be introduced as a standard treatment option
Continuing standard 'treatment as usual' is the most cost-effective approach, despite patient and practitioner dissatisfaction with current options
The absence of cost-effective treatment alternatives represents a significant clinical and policy challenge
Remaining Questions
Do the short-term fatigue improvements from pragmatic rehabilitation translate to longer-term quality-of-life gains beyond the trial period?
What This Study Does Not Prove
This study does not prove that pragmatic rehabilitation or supportive listening are ineffective treatments—only that they may not justify their cost within the healthcare system studied. The results are time-limited to the trial period and may not reflect longer-term outcomes or different healthcare contexts. Short-term fatigue reduction does not necessarily translate to sustained quality-of-life improvement.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
How do results generalize to other healthcare systems with different cost structures and delivery models?
What explains patient and practitioner dissatisfaction with standard care despite its cost-effectiveness, and are there alternative low-cost interventions that could address this gap?
Does the Oxford diagnostic criteria define a homogeneous patient population, and might cost-effectiveness vary by ME/CFS phenotype or severity?